Activation of multiple NF-kappa B/Rel DNA-binding complexes by tumor necrosis factor - PubMed (original) (raw)
Affiliations
- PMID: 8152812
Activation of multiple NF-kappa B/Rel DNA-binding complexes by tumor necrosis factor
A A Beg et al. Oncogene. 1994 May.
Abstract
NF-kappa B is an inducible transcription factor that regulates the expression of numerous genes involved in immune and inflammation responses and in cellular growth control. Typically, NF-kappa B is localized in the cytoplasm complexed with members of the I kappa B family. The most well characterized form of NF-kappa B is comprised of a heterodimer of a 50 kD (p50/NFKB1) and a 65 kD (p65/RelA) protein. This heterodimeric protein was thought to be primarily responsible for transcriptional regulation of target genes. However, recent studies have led to the identification of other kappa B binding proteins such as c-Rel, RelB and p52 (NFKB2/lyt-10) although their role in gene regulation has been less clear. Here, using gel mobility shift assays as well as a highly sensitive DNA-protein crosslinking assay, we provide evidence for the existence of multiple tumor necrosis factor (TNF)- inducible kappa B binding complexes containing various members of the NF-kappa B/Rel family, namely p50 and p65 as well as the c-Rel and p52 oncoproteins. Dimeric complexes containing various combinations of these proteins appear rapidly in nuclei of TNF-alpha-stimulated cells and include, along with a p50-p65 heterodimer, p50-c-Rel, p65-c-Rel, p52-c-Rel and p52-p65 complexes. The presence of multiple inducible complexes containing distinct combinations of NF-kappa B/Rel family members indicate that specific kappa B responsive genes may be regulated in an NF-kappa B subunit-dependent manner.
Similar articles
- Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.
Cogswell PC, Guttridge DC, Funkhouser WK, Baldwin AS Jr. Cogswell PC, et al. Oncogene. 2000 Feb 24;19(9):1123-31. doi: 10.1038/sj.onc.1203412. Oncogene. 2000. PMID: 10713699 - Distinct NF-kappa B/Rel transcription factors are responsible for tissue-specific and inducible gene activation.
Lernbecher T, Müller U, Wirth T. Lernbecher T, et al. Nature. 1993 Oct 21;365(6448):767-70. doi: 10.1038/365767a0. Nature. 1993. PMID: 7692309 - Multiple redox regulation in NF-kappaB transcription factor activation.
Piette J, Piret B, Bonizzi G, Schoonbroodt S, Merville MP, Legrand-Poels S, Bours V. Piette J, et al. Biol Chem. 1997 Nov;378(11):1237-45. Biol Chem. 1997. PMID: 9426183 Review. - Nf-kappa B: an important transcription factor in photobiology.
Legrand-Poels S, Schoonbroodt S, Matroule JY, Piette J. Legrand-Poels S, et al. J Photochem Photobiol B. 1998 Aug 21;45(1):1-8. doi: 10.1016/S1011-1344(98)00118-3. J Photochem Photobiol B. 1998. PMID: 9819895 Review.
Cited by
- RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter.
Lai JH, Horvath G, Subleski J, Bruder J, Ghosh P, Tan TH. Lai JH, et al. Mol Cell Biol. 1995 Aug;15(8):4260-71. doi: 10.1128/MCB.15.8.4260. Mol Cell Biol. 1995. PMID: 7623820 Free PMC article. - Modulation of the NFκb Signalling Pathway by Human Cytomegalovirus.
Hancock MH, Nelson JA. Hancock MH, et al. Virology (Hyderabad). 2017 Aug;1(1):104. Epub 2017 Jul 31. Virology (Hyderabad). 2017. PMID: 29082387 Free PMC article. - Lipopolysaccharide activates nuclear factor kappaB in rat intestine: role of endogenous platelet-activating factor and tumour necrosis factor.
De Plaen IG, Tan XD, Chang H, Wang L, Remick DG, Hsueh W. De Plaen IG, et al. Br J Pharmacol. 2000 Jan;129(2):307-14. doi: 10.1038/sj.bjp.0703055. Br J Pharmacol. 2000. PMID: 10694237 Free PMC article. - Enhanced responsiveness to nuclear factor kappa B contributes to the unique phenotype of simian immunodeficiency virus variant SIVsmmPBj14.
Dollard SC, Gummuluru S, Tsang S, Fultz PN, Dewhurst S. Dollard SC, et al. J Virol. 1994 Dec;68(12):7800-9. doi: 10.1128/JVI.68.12.7800-7809.1994. J Virol. 1994. PMID: 7966569 Free PMC article. - Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas.
Weaver KD, Yeyeodu S, Cusack JC Jr, Baldwin AS Jr, Ewend MG. Weaver KD, et al. J Neurooncol. 2003 Feb;61(3):187-96. doi: 10.1023/a:1022554824129. J Neurooncol. 2003. PMID: 12675310
Publication types
MeSH terms
Substances
LinkOut - more resources
Molecular Biology Databases
Research Materials
Miscellaneous